<i>ERBB2</i>-Low Expression by Race and Ethnicity Among Patients With Triple-Negative Breast Cancer
In this cohort study of patients with TNBC, ERBB2-low expression and its association with clinical outcomes varied across racial and ethnic groups. These findings highlight the need for further research to understand the biological implications of ERBB2-low expression in diverse populations of patients with TNBC.
Authors
- Ton Wang (ORCID: https://orcid.org/0000-0003-0437-3771)
- Jennifer Kay Plichta (ORCID: https://orcid.org/0000-0002-7411-0558)
- Akiko Chiba (ORCID: https://orcid.org/0000-0003-0303-2799)
- Maggie Lee DiNome (ORCID: https://orcid.org/0000-0002-1926-292X)
- Samantha Marie Thomas (ORCID: https://orcid.org/0000-0002-1561-9303)
- Astrid Botty van den Bruele
- Hannah E. Woriax (ORCID: https://orcid.org/0000-0002-8746-6457)
- Laura Horst Rosenberger (ORCID: https://orcid.org/0000-0002-6829-6747)
- Kendra Modell Parrish
- Kerri‐Anne Crowell
Institutions
- Duke University (US)
- Duke Medical Center (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-06-11
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.14864
- Citations
- 1
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.94